Transdermal Estrogen for the Treatment of Bone Loss in Women with Anorexia Nervosa: A Randomized, Placebo-controlled Trial

Protocol Description

This study will investigate the effects of transdermal estrogen on bone mineral density in women with anorexia nervosa in an 18-month randomized, placebo-controlled trial.

Eligibility Criteria

  • Women with anorexia nervosa and amenorrhea, ages 20 to 45
  • Are currently diagnosed with anorexia nervosa
  • Are NOT currently using hormonal contraceptives

Status: Open to Enrollment

Additional Information

Adolescent Medicine Research


Participants will receive up to $575 in compensation.

Contact Information

Soukaina Eljamri at